Scinai Immunotherapeutics Ltd. SCNI
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$0.52$0.57
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.00M | -2.09M | -2.09M | -2.09M | -2.58M |
| Total Depreciation and Amortization | 586.00K | 358.50K | 358.50K | 358.50K | 353.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -190.00K | 194.50K | 194.50K | 194.50K | 293.00K |
| Change in Net Operating Assets | -857.00K | -194.50K | -194.50K | -194.50K | 397.00K |
| Cash from Operations | -2.46M | -1.73M | -1.73M | -1.73M | -1.53M |
| Capital Expenditure | -112.00K | -6.00K | -6.00K | -6.00K | -3.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -112.00K | -6.00K | -6.00K | -6.00K | -3.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 2.09M | 2.09M | 2.09M | 1.48M |
| Repurchase of Common Stock | -6.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.32M | -- | -- | -- | -- |
| Cash from Financing | 2.32M | 2.09M | 2.09M | 2.09M | 1.48M |
| Foreign Exchange rate Adjustments | -- | -20.50K | -20.50K | -20.50K | 42.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -261.00K | 340.00K | 340.00K | 340.00K | -18.00K |